Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Fanconi Anemia, Complementation Group L (FANCL) Peptid

FANCL Reaktivität: Säugetier Wirt: Synthetic BP, IHC, WB
Produktnummer ABIN936892
  • Target Alle FANCL Produkte
    FANCL (Fanconi Anemia, Complementation Group L (FANCL))
    Protein-Typ
    Synthetic
    Spezies
    Säugetier
    Quelle
    • 3
    Synthetic
    Applikation
    Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
    Sequenz
    ASGREHLITL KLKAKYPAES PDYFVDFPVP FCASWTPQVN SPQSSLISIY
    Produktmerkmale
    A synthetic peptide for use as a blocking control in assays to test for specificity of FANCL antibody,
    Alternative Names: FANCL control peptide, FANCL antibody Blocking Peptide, Anti-FANCL Blocking Peptide, Fanconi Anemia Complementation Group L Blocking Peptide, FAAP43 Blocking Peptide, FLJ10335 Blocking Peptide, PHF9 Blocking Peptide, POG Blocking Peptide
  • Applikationshinweise
    Optimal conditions should be determined by the investigator
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20 °C long term.
  • Target
    FANCL (Fanconi Anemia, Complementation Group L (FANCL))
    Synonyme
    FAAP43 Peptide, PHF9 Peptide, POG Peptide, 2010322C19Rik Peptide, AW554273 Peptide, B230118H11Rik Peptide, Phf9 Peptide, Pog Peptide, gcd Peptide, Fanconi anemia complementation group L Peptide, Fanconi anemia, complementation group L Peptide, FANCL Peptide, Fancl Peptide
    Hintergrund
    The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.
    Molekulargewicht
    42 kDa
Sie sind hier:
Kundenservice